The risk of bladder cancer in Korean diabetic subjects treated with pioglitazone

Sun Ok Song, Kwang Joon Kim, Byung Wan Lee, Eun Seok Kang, Bong Soo Cha, Hyun Chul Lee

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Background: There is growing concern regarding the increased incidence of bladder cancer in diabetic patients using pioglitaz. This study aimed to investigate the association between bladder cancer and the use of pioglitazone in Korean diabetics. Methods: Th retrospective, matched case-control study included a case group (n=329) of diabetic patients with bladder cancerwho presented at theSeverance Hospital from November 2005 to June 2011. The control group consisted of patients without bladder cancer (1:2 ratio mtchin for sex and age, n=658) who were listed on the Severance Hospital diabetes registry. Results: The percentage of subjects who had eve used pioglitazone was significantly lower in the case group than in the control group (6.4% vs. 15.0%, P<0.001). Multivaria onditional logistic analysis revealed that independent factors affecting bladder cancer were smoking (odds ratio [OR], 11.64; 95% cofidence interval [CI], 6.56 to 20.66; P<0.001), coexisting cancer (OR, 6.11; 95% CI, 2.25 to 16.63; P<0.001), and hemoglobin levels OR, 0.78; 95% CI, 0.69 to 0.88; P<0.001). The OR of the history of pioglitazoneuse was 2.09 and was not significantly different between the two groups (95% CI, 0.26 to 16.81; P=0.488). Conclusion: A relationship between pioglitazone use and incidence of bladder cancer was not observed in Korean diabetic patients.This suggests that the risk for bladder cancer in Korean diabetic subjects treated ith pioglitazone might be different from that of Caucasian populations. Large-scale, well-designed and multi-center studies are needed to further evaluate this relationship.

Original languageEnglish
Pages (from-to)371-378
Number of pages8
JournalDiabetes and Metabolism Journal
Volume36
Issue number5
DOIs
Publication statusPublished - 2012 Oct 1

    Fingerprint

All Science Journal Classification (ASJC) codes

  • Endocrinology, Diabetes and Metabolism

Cite this